Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.5186
-0.0051 (-0.97%)
At close: Mar 18, 2026, 4:00 PM EDT
0.5254
+0.0068 (1.31%)
After-hours: Mar 18, 2026, 7:04 PM EDT
Onconetix Employees
Onconetix had 5 employees as of December 31, 2024. The number of employees decreased by 7 or -58.33% compared to the previous year.
Employees
5
Change (1Y)
-7
Growth (1Y)
-58.33%
Revenue / Employee
$163,074
Profits / Employee
-$3,106,187
Market Cap
1.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 5 | -7 | -58.33% |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | 7 | 140.00% |
| Dec 31, 2021 | 5 | - | - |
| Sep 30, 2021 | 2 | - | - |
| Jun 30, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| KALA BIO | 38 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 28 |
| Azitra | 12 |
| BioRestorative Therapies | 11 |
| Ensysce Biosciences | 8 |
| Adial Pharmaceuticals | 5 |
ONCO News
- 4 weeks ago - Onconetix, Inc. (ONCO) M&A Call Transcript - Seeking Alpha
- 4 weeks ago - Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company - GlobeNewsWire
- 4 weeks ago - Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer - Business Wire
- 6 months ago - Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewsWire
- 6 months ago - Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement - GlobeNewsWire
- 6 months ago - Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM - GlobeNewsWire
- 8 months ago - Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewsWire
- 9 months ago - Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewsWire